Видео ютуба по тегу Tdp-43

Dr Adekunle Bademosi | Understanding TDP-43 aggregation in frontotemporal dementia
Dr Adekunle Bademosi | Understanding TDP-43 aggregation in frontotemporal dementia
TDP-43 Pathology in the ALS Motor Cortex
TDP-43 Pathology in the ALS Motor Cortex
Investigating TDP-43 pathology with cryptic exons
Investigating TDP-43 pathology with cryptic exons
USER TALK: How TDP-43 Condensation Modulates its RNA Processing and How This is Relevant for ALS
USER TALK: How TDP-43 Condensation Modulates its RNA Processing and How This is Relevant for ALS
M. Neumann - TDP-43 , FUS and beyond...
M. Neumann - TDP-43 , FUS and beyond...
Gene Therapy Targeting TDP-43 Mediated Diseases Pitch
Gene Therapy Targeting TDP-43 Mediated Diseases Pitch
Elizabeth Head, MA, PhD - TDP-43 pathology in Down Syndrome and Alzheimer Disease
Elizabeth Head, MA, PhD - TDP-43 pathology in Down Syndrome and Alzheimer Disease
Developing antibodies against pathogenic TDP-43 in ALS
Developing antibodies against pathogenic TDP-43 in ALS
What Causes ALS? | Research Revealed | TDP-43
What Causes ALS? | Research Revealed | TDP-43
From embryonic development to cancer: The many functions of TDP-43
From embryonic development to cancer: The many functions of TDP-43
Using antibodies and intrabodies to target pathogenic TDP-43 in ALS
Using antibodies and intrabodies to target pathogenic TDP-43 in ALS
"Stathmin-2: An Emerging Therapeutic Target in TDP-43 Proteinopathies"
Gregory A. Jicha, MD, PhD - Is TDP-43 a confound in ADRD clinical trials? And is it too LATE...
Gregory A. Jicha, MD, PhD - Is TDP-43 a confound in ADRD clinical trials? And is it too LATE...
TDP43 and Alzheimer's Study
TDP43 and Alzheimer's Study
TDP-43 aggregation drives loss of UNC13A, a risk gene for ALS & FTD
TDP-43 aggregation drives loss of UNC13A, a risk gene for ALS & FTD
F. Chiti - Structure of TDP-43 aggregates and assessment of whether TDP-43 proteinopathies..
F. Chiti - Structure of TDP-43 aggregates and assessment of whether TDP-43 proteinopathies..
Sandra Tomé, PhD - Tau and TDP-43 synergy in Alzheimer’s Disease with LATE-NC
Sandra Tomé, PhD - Tau and TDP-43 synergy in Alzheimer’s Disease with LATE-NC
K. Talbot - Physiological models of TDP-43 related amyotrophic lateral sclerosis
K. Talbot - Physiological models of TDP-43 related amyotrophic lateral sclerosis
A. Acevedo Arozena - New models and mechanisms of TDP-43 proteinopathies
A. Acevedo Arozena - New models and mechanisms of TDP-43 proteinopathies
Drug-like Molecules Decrease Toxic Protein Clumping in ALS
Drug-like Molecules Decrease Toxic Protein Clumping in ALS